(TAMPA, FLORIDA, USA, 12 OCTOBER 2015) – ISPE announced the results of its 2015 – 2016 International Board of Directors election, revealing a slate of strategic leaders who represent a variety of pharmaceutical industry sectors. The Board is responsible for the governance and strategic direction of the Society and will assume their elected positions at the 2015 ISPE Annual Meeting, 8-11 November in Philadelphia, PA, USA.
“ISPE is in the midst of significant growth and transformation,” said ISPE President and CEO John Bournas. “I am confident that the incoming International Board of Directors will build upon past successes and lead the Society in its mission to support the manufacture of quality medicines for patients around the world.”
The following pharmaceutical industry leaders have been elected to positions on the 2015 – 2016 ISPE International Board of Directors:
Continuing Board Members:
In addition to those named above, the following Directors were elected in 2014 to serve a two year term and will continue their service on the Board:
The 2014-2015 Board Chair will continue service on the Board in 2015-2016 as Immediate Past Chair:
Complete biographical information on all of ISPE’s Directors can be found at the ISPE Board ofDirectors webpage.
ISPE, the International Society for Pharmaceutical Engineering, is the world’s largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has headquarter offices in Tampa, Florida and Bethesda, Maryland USA. Visit: www.ISPE.org or more information.
For more information contact:
Senior Director, Marketing Communications
International Society for Pharmaceutical Engineering (ISPE)
Tel: +1-813-960-2105, ext. 404
Innovation Forum – Connecting with Thought Leaders
Wednesday, 27 Jul 2016 14.07
Reimagining Medicine – The Novartis Mission
Tuesday, 26 Jul 2016 13.07
GAMP Cloud Special Interest Group Concept Papers
Monday, 25 Jul 2016 14.07